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Abstract
Objective:  To determine the prevalence of malaria and anaemia in 
HIV-infected persons and the effect of age, gender and CD4+T cell 
counts thereon.                                                       
Methods:  Blood samples were collected from 491 patients (240 
female) attending an out patient clinic. Malaria parasitaemia 
was diagnosed by microscopy while anaemia was defi ned as 
haemoglobin concentration <130g/L in males and <120g/L in 
females. The CD4 + T cell count was estimated by fl ow cytometry.          
Results:  HIV infection was a risk factor for malaria infection 
(OR: 16.31; 95% CI: 7.41-35.87; p < 0.0001). CD4+T cell counts was 
equally a signifi cant risk factor in malaria infection among HIV-
infected patients (OR: 1.96; 95% CI: 1.28-3.02; p = 0.002). The 
prevalence of anaemia was signifi cantly affected by HIV-infection 
(OR: 25.12; 95% CI: 11.42-55.28; p < 0.0001) while age was not 
associated with increased risk of malaria infection (p=0.13). 
Conclusions: A prevalence of 46.0% of malaria infection among 
HIV-infected was observed. HIV-infected patients were more likely 
to develop malaria and anaemia, while CD4+T cell counts < 200cells/
µL was associated with an increased risk of malaria infection 
among HIV-infected. Age and gender did not affect the prevalence 
of malaria. HIV status should be considered early in the diagnostic 
evaluation of patients with suspected malaria and anaemia.
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Introduction
More than 40 million people are living with HIV/AIDS while the 
majority (more than 25 million) are in sub-Saharan Africa and up to 
2.4 million deaths were recorded in 2005 (1). Each year 500 million 
infections and up to 2.7 million deaths are attributable to malaria 
(2). Malaria and HIV are among the two most important global 
health problems of our time, together they cause more than 4 
million deaths per year. Malaria and HIV/AIDS are both diseases 
and causes of poverty and they share determinants of vulnerability 
(3). Both diseases kill millions of people each year and both are 
scourges of developing nations in Africa, India, Southeast Asia 
and South America (4). Since HIV- infection interferes with cellular 
immune function, protection against malaria depends on cellular 
immunity, which may be impaired in HIV-infected persons with low 
CD4 + T cell counts (5). 
Anaemia is one of the complications in both malaria and HIV 
infections and contributes to its morbidity and mortality (6). 
Previous studies have revealed malaria as fueling the spread of HIV 
in sub-Saharan Africa, while HIV is been implicated as playing a role 
in boosting adult malaria infection rates (7). This has not been well 
studied in this locality, therefore we determined the prevalence of 
malaria and anaemia in HIV-infected persons as well as the effect 
of age, gender and CD4+ T cell counts thereon.
Methods 
Study population
The study was conducted in the University of Benin Teaching 
Hospital (a tertiary hospital with a referral status), Benin City, Edo 
State, Nigeria, between March 2008 and March 2009. A total of 350 
HIV-infected and 141 HIV non-infected patients as controls (251 
males and 240 females) were studied. Age of study subjects ranged 
from 20 to 70 years (mean: 34.3 ± 9. 4 years). All enrolled subjects 
were out patients that were on their fi rst hospital visit before 
commencement of HAART therapy. Verbal informed consent was 
obtained from each subject before specimen collection. The study 
was approved by the Ethical Committee of the University of Benin 
Teaching Hospital.
Specimen collection and processing
About four to fi ve milliliters of blood was obtained from each 
patient, dispensed into ethylene diamine tetra-acetic acid (EDTA) 
container and mixed. Malaria was diagnosed by examination of a 
stained thick blood fi lm. Thick blood fi lms were made from each 
blood sample and allowed to air-dry. Slides were stained in 3% 
Giemsa stain for 30 minutes, rinsed in tap-water and allowed to 
air-dry. The stained fi lms were examined for malaria parasites by 
microscopy using a x100 oil immersion objective lens. A total of 200 
fi elds per fi lm were examined (8). 
Haemoglobin estimation was determined using a Sysmex KX – 
21 haematology analyzer (Sysmex Corporation, Kobe, Japan). 
Anaemia was defi ned as a haemoglobin concentration less than 
130 g/L in males and 120 g/L in females (9). A CD4+ T cell count was 
analyzed using fl ow cytometry (Partec, Gmbh, Germany). Briefl y, 
into a Partec test tube 20µl CD4 PE antibody and 20 µl of well 
mixed whole EDTA blood were added, mixed gently and incubated 
in the dark for 15 minutes at room temperature. This mixture was 
mixed during incubation every 5 minutes. Eight hundred µl of 
CD4 buffer was added to the mixture of antibody and sample and 
mixed gently and  CD4+ T cells counted.
Statistical analysis 
Data were analyzed using chi square (X2) test or Fisher’s exact test 
as appropriate and odd ratio analysis, using the statistical software 
INSTAT®.
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Results
A total of 168 (34.2%) out of 491 patients had malaria, while 161 
(46.0%) out of 350 HIV-infected patients had malaria and 7 (4.97%) 
out of 141 HIV non-infected patients had malaria. Generally, HIV-
infection was a signifi cant risk factor for malaria (OR: 16.31; 95% 
CI: 7.41-35.87;p<0.0001) (Table 1). The prevalence of malaria was 
not signifi cantly affected by gender (OR: 0.70; 95% CI: 0.46-1.07; 
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p = 0.097) (Table 1).  CD4+ T cell count was a signifi cant risk factor 
for malaria infection among HIV-infected patients (OR: 1.96; 95% 
CI: 1.28-3.02; p = 0.002) (Table 2). The prevalence of anaemia was 
signifi cantly affected by HIV infection (OR: 25.12; 95% CI: 11.42-
55.28; p < 0.0001) (Table 2).    
                                                                                                                   
Increasing age was not associated with increased risk of malaria 
infection (p = 0.13). Although females had a higher prevalence of 
malaria than males, this was not statistically signifi cant (p=0.097). 
Age was a signifi cant risk factor for development of anaemia in 
HIV-infected patients (p = 0.040). The 20 – 29 and 50 – 59 year 
age groups showed the highest prevalence of anaemia (64.5% and 
64.7% respectively) with the 40 – 49 year age group showing the 
lowest prevalence of anaemia (42.9%) in relation to age.
                                                                  
Table 1: Prevalence of malaria and anaemia
N No. of 
positive 
cases 
OR 95% CI p 
Malaria
HIV infected 350 161 (46.0%) 16.31 7.41-35.87 <0.0001
Non-HIV 141 7 (5.0%)
Anaemia
HIV infected 350 198 (56.6%) 25.12 11.42-55.28 < 0.0001
Non-HIV 141 6 (4.3%)
Table 2: Risk factors for malaria among HIV patients
N No. of 
Positive 
cases 
OR 95% CI P value
CD4+count
cells/µL
< 200 195 104 (53.3%) 1.96 1.28-3.02 0.003
≥ 200 155 57 (36.8%)
Gender
Male 195 82 (42.1%) 0.70 0.46-1.07 0.097
Female 155 79 (51.0%)
Age (yrs)                                                        Malaria
20 – 29 121 56 (46.3%)
30 – 39 85 32 (37.7%)
40 – 49 63 30 (47.6%)
50 – 59 68 39 (57.4%)
≥ 60 13 4 (30.8%) 0.126
Discussion
Malaria may be helping to spread the HIV-virus that causes AIDS 
(3). HIV-infected patients are at higher risk for malaria because 
of their weakened immune systems. Sub-Saharan Africa carries 
a high burden of both diseases thus co-infection is common in 
many areas there (10). This study focused on determining the 
prevalence of malaria and anaemia among HIV-infected patients 
as well as the effect of age, gender and CD4 + T cell counts on its 
prevalence.                                         A prevalence of 46.0% of malaria 
infection among HIV-infected patients was observed in this study. 
This is a relatively high prevalence that may be due to poor control 
measures. In countries like Togo, long-lasting insecticide treated 
nets have been distributed throughout the country (11). This kind 
of control programme has not been done in Nigeria, particularly, 
Benin City. There is therefore a need for an effective control 
programme to stem the tide of high malaria prevalence. 
HIV infection was a risk factor for acquiring malaria infection 
in our study. This is consistent with previous fi ndings (12). HIV-
infected adults are more likely to develop malaria (13, 14), again 
consistent with our fi ndings. The reason for this may be due to their 
weakened immune system induced by the HIV virus. However, Berg 
et al reported no signifi cant association between HIV infection and 
malaria (15). 
HIV infection has also been reported as an important risk factor 
for anaemia (12,16). Similarly, in our study HIV-infected patients 
were observed to have on 11 – 55 fold increased risk for acquiring 
anaemia. Bone marrow suppression by the HIV virus has been 
reported as a mechanism of anaemia among HIV-infected patients 
(17). CD4+ T cell counts is used as a measure of immunity and HIV 
disease progression (18) and counts less than 200cells/µL increases 
the risk of opportunistic infections. In our study CD4+ count of 
<200cells/µL was associated with an increased risk of malaria 
infection among HIV infected patients. This is in agreement with 
the fi ndings of Whitwort et al (14) but not with that of Laufer et 
al (12). A decline in CD4+ T cell counts below 200cells/µL increases 
immunosuppression and the risk of contracting an opportunistic 
infection. 
                                                                                                                                                      
                                                                  
Age and gender did not signifi cantly affect the prevalence of 
malaria, a fi nding consistent with a previous report (15). It seems 
that the level of immunosuppression among HIV-infected  patients 
determines the prevalence of malaria. However, in relation to 
anaemia,  in our study age affected its prevalence among HIV-
infected patients with those between 40 – 49 years of age having 
the lowest prevalence. The reasons for this are not clear. Among 
HIV patients with malaria, an anaemia prevalence of 70.7% was 
observed in this study (data not shown). The combined effect of 
malaria and HIV infection on erythropoiesis and red cell survival may 
be responsible for the higher prevalence of anaemia observed.
In conclusion, we observed a prevalence of 46.0% of malaria 
infection among HIV infected patients. HIV-infected patients are 
more likely to develop malaria and anaemia, while a CD4+T cell 
count of < 200cells/µL was associated with an increased risk of 
malaria infection among HIV-infected patients. Age and gender 
did not affect the prevalence of malaria. The knowledge of HIV 
status may be valuable in the diagnostic evaluation of patients 
with suspected malaria and anaemia. 
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